Cell-Easy
PrivateLast Round
Grant
Apr 14, 2026
Total Funding Raised
$18.31M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Cell-Easy is a biotechnology company that operates as a Contract Development and Manufacturing Organization (CDMO) specializing in cell therapy, providing services from process development to GMP production for biotech and pharma companies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Quality Management
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cell-Easy Comparables
Compare Cell-Easy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stemmatters | 86% | |
| Cellex Cell Professionals GmbH | 82% | |
| Cellistic | 82% | |
Cell-Easy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 14, 2026 | ||||
| Grant | Feb 28, 2022 | ||||
| Series A | Dec 8, 2020 | ||||
| Angel | Dec 1, 2019 |
Key People
Founding team and executive leadership
Cell-Easy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Région Occitanie | Grant |
| M Capital | Series A |
| IRDI Soridec Gestion | Series A |
| Bpifrance | Grant |
| Mérieux Equity Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 12, 34% of headcount.
- Jul 27, 2026
Grew 16% QoQ, from 32 to 37 employees.
Cell-Easy Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cell-Easy's valuation, stock price, and market status.